共 50 条
The patient impact of 10 years of ocrelizumab treatment in multiple sclerosis: long-term data from the Phase III OPERA and ORATORIO studies
被引:0
|作者:
Weber, Martin
[1
,2
,3
]
Kappos, Ludwig
[4
]
Hauser, Stephen
[5
]
Nicholas, Jacqueline
[6
]
Schneble, Hans-Martin
[7
]
Wang, Qing
[7
]
Giovannoni, Gavin
[8
]
Filippi, Massimo
[9
,10
]
机构:
[1] Inst Neuropathol, Dept Neurol, Gottingen, Germany
[2] Univ Med Ctr, Gottingen, Germany
[3] Fraunhofer Inst Translat Med & Pharmacol ITMP, Gottingen, Germany
[4] Univ Basel, Univ Hosp Basel, Res Ctr Clin Neuroimmunol & Neurosci, Basel, Switzerland
[5] Univ Calif San Francisco, UCSF Weill Inst Neurosci, San Francisco, CA USA
[6] OhioHlth Multiple Sclerosis Clin, Columbus, OH USA
[7] F Hoffmann La Roche Ltd, Basel, Switzerland
[8] Queen Mary Univ London, London, England
[9] IRCCS San Raffaele Sci Inst, Neurol Unit, Neurophysiol Serv, Neurorehabil Unit,Neuroimaging Res Unit,Div Neuro, Milan, Italy
[10] Univ Vita Salute San Raffaele, Milan, Italy
关键词:
D O I:
暂无
中图分类号:
R74 [神经病学与精神病学];
学科分类号:
摘要:
P302/406
引用
收藏
页码:350 / 351
页数:2
相关论文